{"id":"NCT02814643","sponsor":"AstraZeneca","briefTitle":"Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma","officialTitle":"A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3b Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-07-01","primaryCompletion":"2017-01-24","completion":"2017-01-24","firstPosted":"2016-06-28","resultsPosted":"2018-03-01","lastUpdate":"2018-10-24"},"enrollment":103,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Benralizumab","otherNames":[]},{"type":"DRUG","name":"Benralizumab Placebo","otherNames":[]},{"type":"DRUG","name":"Seasonal influenza virus vaccine","otherNames":[]}],"arms":[{"label":"Benralizumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, double-blind, parallel group, placebo-controlled study designed to investigate the potential effect of a fixed dose of benralizumab administered subcutaneously (SC) on antibody responses following seasonal influenza virus vaccination","primaryOutcome":{"measure":"Postdose Strain-specific Hemagglutination-inhibition (HAI) Antibody Geometric Mean Fold Rise From Week 8 to Week 12","timeFrame":"4 weeks","effectByArm":[{"arm":"Benralizumab 30mg","deltaMin":3.6,"sd":1.22},{"arm":"Placebo","deltaMin":3.13,"sd":1.22}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":5},"locations":{"siteCount":24,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=3366&filename=d3250c00033-clinical-study-protocol_Redacted.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=3366&filename=d3250C00033-sap-edition-2_redacted.pdf","http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=3366&filename=ALIZE_redacted_protocol.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":51},"commonTop":["Nasopharyngitis","Headache","Asthma","Oropharyngeal pain","Gastroenteritis viral"]}}